Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7 Gastrointestinal 6 Sarcoma 2 Plasma cell 1 Dermatologic 1

Conditions

Melanoma 322 Skin Neoplasms 164 Carcinoma, Basal Cell 90 Keratosis, Actinic 62 Lymphoma, T-Cell, Cutaneous 60 Breast Neoplasms 59 Leukemia, Lymphocytic, Chronic, B-Cell 47 Precursor Cell Lymphoblastic Leukemia-Lymphoma 46 Mycosis Fungoides 46 Lymphoma, Non-Hodgkin 46 Sezary Syndrome 44 Lymphoma, Follicular 44 Lymphoma, Large B-Cell, Diffuse 43 Lymphoma, B-Cell, Marginal Zone 43 Lymphoma, Mantle-Cell 42 Burkitt Lymphoma 42 Hodgkin Disease 41 Carcinoma, Squamous Cell 41 Lymphoma, Large-Cell, Immunoblastic 40 Neoplasms 39 Multiple Myeloma 39 Lymphoma 39 Leukemia, Myeloid, Acute 35 Leukemia, Myeloid, Accelerated Phase 32 Myeloproliferative Disorders 31 Leukemia, Myeloid, Chronic-Phase 31 Congenital Abnormalities 30 Leukemia, Hairy Cell 29 Sarcoma 28 Primary Myelofibrosis 28

Interventions

Cell-Free Nucleic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Pathologic Complete Response × Dermatologic × Clear all

NCT02907827 2020-12-17

DW-MRi

Universitair Ziekenhuis Brussel

Phase NA Unknown

Pathologic Complete Response, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡